Stocks rise for 3rd straight session

Capital Market 

Key equity indices rose for third consecutive session as geopolitical tensions between and appeared to be easing. The barometer index, the S&P BSE Sensex, rose 193.56 points or 0.53% to 36,636.10, as per the provisional closing data. The index rose 65.55 points or 0.60% to 11,053, as per the provisional closing data.

After opening higher, indices pared gains in morning trade. Benchmarks firmed up once again in mid-morning trade and were trading near the day's high in early afternoon trade. Indices turned range bound at higher levels in afternoon trade. Barometers hit fresh intraday high in late trade. The Nifty ended above the psychologically important 11,000 mark.

The market breadth, indicating the overall health of the market, was strong. On BSE, 1662 shares rose and 1038 shares fell. A total of 150 shares were unchanged.

Among secondary barometers, the BSE Mid-Cap index rose 0.49%. The BSE Small-Cap index rose 0.97%.

(down 2.27%), (down 1.78%), (down 1.46%), (down 1.24%), (down 1%) and (down 0.96%), were the major Sensex losers.

(up 2.52%), (up 2.26%), (up 2.06%), (up 2.03%), (up 1.89%) and (up 1.37%), were the major Sensex gainers.

rose 0.80% after the company announced collaboration with Zoom Video Communications, Inc., a modern enterprise video-first unified communications service, to launch India's first high quality Unified offering, an integrated and secure platform for High Definition (HD) audio, video and The announcement was made after market hours yesterday, 5 March 2019.

was up 0.45%. The company announced during trading hours today, 6 March 2019, that heavy civil infrastructure business of L&T Construction has secured orders from for the design and construction of the phase - 2 works.

was down 0.46%. before trading hours today, 6 March 2019, announced a phased launch of generic hydrochloride tablets (30mg, 60mg and 90mg) in the USA. The launch is a subject of ongoing litigation.

Cipla's hydrochloride tablets (30mg, 60mg and 90mg) is AB-rated generic therapeutic equivalent version of Sensipar, a branded drug marketed by Amgen, Inc. tablets are indicated for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on dialysis, for the treatment of hypercalcemia in adult patients with Parathyroid Carcinoma, and for treatment of severe hypercalcemia in adult patients with primary HPT who are unable to undergo parathyroidectomy.

(DHFL) was up 10.82%. The company announced that an independent chartered firm placed its report to the audit committee members saying that DHFL did not create shell to divert funds, but deviated from internal lending practices which exposes a significant amount of loans to the risk of turning sour. The announcement was made after market hours yesterday, 5 March 2019.

On the economic front, the unemployment rate in February 2019 was 7.2%. This was higher than the 7.1% unemployment rate in January 2019 and much higher than the 5.9% unemployment rate in February 2018 or the 5% in February 2017, according to data compiled by the Centre for Monitoring Indian Economy (CMIE) that was released on Tuesday.

The and the Government of on 5 March 2019 signed a $250 million agreement for the National Rural Economic Transformation Project (NRETP) which will help women in rural households shift to a new generation of economic initiatives by developing viable enterprises for farm and A key focus of the project will be to promote women-owned and women-led farm and non-farm enterprises across value chains; enable them to build businesses that help them access finance, markets and networks; and generate employment. The $250 million loan from the (IBRD), has a 5-year grace period, and a final maturity of 20 years.

Overseas, shares in and were mixed, following an overnight slip on Wall Street as investors watched developments on the US-trade front.

US stocks finished lower Monday, as investors turned cautious after initially cheering reports that the US and were close to completing a landmark trade deal. Profit booking on the back of a two-month rally from December lows also weighed on sentiment.

On the US data front, the Institute for Supply Management's survey of senior executives at banks, retailers, restaurants and the like rose to 59.7% last month from 56.7% in January.

Meanwhile, the US plans to end preferential trade status for India, under a scheme which allows certain products to enter the US duty-free. reportedly said had failed to assure the US it would provide reasonable access to its markets. India said the US move would have a "minimal economic impact".

of America on 5 March 2019 gave a 60-day withdrawal notice to India on the Generalized System of Preferences (GSP) benefits extended by US. GSP benefits are envisaged to be non-reciprocal and non-discriminatory benefits extended by developed countries to developing countries. In India's case the GSP concessions extended by the US amounted to duty reduction of only $190 million per annum.

The issue of Indian tariffs being high has been raised from time to time. It is pertinent that India's tariffs are within its bound rates under WTO commitments, and are on the average well below these bound rates. India's trade weighted average tariffs are 7.6%, which is comparable with the most open developing economies, and some developed economies. On developmental considerations there may be a few tariff peaks, which is true for almost all economies. India was agreeable to a very meaningful mutually acceptable package on the above lines to be agreed to at this time, while keeping remaining issues under discussion in the future, said in a statement on 5 March 2019.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, March 06 2019. 15:37 IST